Fox Business - The Power to Prosper
Search Site

Pfizer

Lululemon shares under pressure over analysts’ concerns

FBN’s Nicole Petallides on the highlights from the day in the markets.

Read More

  1. Midday Market Report: 2/5/15

    Jobless claims rise less than expected

  2. Hospira, Pfizer a good deal?

    Ariel Investments Vice Chairman Charles Bobrinskoy discusses the deal between Pfizer and Hospira and how he’s allocating capital.

  3. Pfizer eyes growth in biosimilar injectable market

    Canaccord Genuity U.S. Portfolio Strategist Tony Dwyer and Glenmede Director of Investment Strategy Jason Pride discuss money flow into the health-care sector.

  4. Pfizer buys Hospira

    FBN’s Liz MacDonald on Pfizer ’s multi-billion dollar bet on Hospira.

  5. UK approves ‘three-person baby’ law

    Fox News Medical A-Team’s Dr. Manny Alvarez discusses the UK’s approval of a ‘three-person baby’ law and the FDA’s approval of Pfizer ’s cancer drug.

  6. OPKO Health shares a ‘buy’ despite high risks?

    FBN’s Charles Payne, BNP Paribas Cash Equity Trading Head Darren Wolfberg A&G Capital CIO Hilary Kramer, NewOak Capital President James Frischling and Penn Financial Group founder Matt McCall on the outlook for OPKO Health.

  7. Can GM turnaround from their legal troubles?

    FBN’s Adam Shapiro, Leeb group Research Chairman Stephen Leeb and Bulls-Eye Options Chief Strategist Alan Knuckman on GM’s compensation fund, recalls and notably absent Super Bowl ads.

  8. Dow Chemical CEO: Low oil prices good for economy

    Dow Chemical CEO Andrew Liveris discusses why lower crude prices are a benefit for his company, and where he looks to profit outside the U.S.

  9. The growing trend of ‘smart drugs’

    Immune Pharmaceuticals CEO Dr. Daniel Teper on the potential risks of ‘smart drugs’ used to enhance your brain and body’s performance.

  10. Pfizer 4Q earnings beat expectations

    Earnings HQ: FBN’s Ashley Webster breaks down Pfizer ’s fourth-quarter earnings report.

  11. Xbox helps boost Microsoft to 2Q revenue beat

    Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Microsoft’s second-quarter earnings and the blizzard bearing down on the Northeast.

  12. How everyone gets caught in the IRS web

    DMS offshore Investment Services Kathleen Celoria explains the IRS going after Americans and Company’s being made to declare their offshore accounts.

  1. Dow kicks out AT&T and puts Apple in

    Fross & Fross Wealth Management Co-Founder Thom Fross, FBN’s Adam Shapiro and SFG Alternatives CIO Larry Shover on Apple taking AT&T’s place in the Dow and Amazon taking on Alibaba.

  2. Gasparino: Morgan Stanley ramps up parody investigation

    FOX Business Senior Correspondent Charlie Gasparino Morgan Stanley’s leaked parody videos, the internal investigation and the costs of the parody videos.

  3. Should the U.S. government be allowed to track potential terrorists?

    Judge Andrew Napolitano discusses the legality of tracking potential terrorists.

  4. The big business of vaccines

    FBN’s Peter Barnes on the big, and growing, vaccine industry.

  5. HSBC skirts the taxman

    FOX Business Contributor Bob Rice discusses the implications of HSBC’s alleges Swiss tax dodge.

  6. UHS CEO on healthcare deals

    Universal Health Services CEO Alan Miller discusses the business of healthcare and recent acquisitions.

  7. Hospira shares rise to new highs on Pfizer deal

    FBN’s Nicole Petallides on the highlights from the day in the markets.

‹ Prev12345Next ›
Freebase CC-BY
Source: Pfizer on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL